{"nct_id":"NCT00802737","title":"Efficacy and Safety of Ofatumumab Retreatment and Maintenance Treatment in Patients With B-cell Chronic Lymphocytic Leukemia (CLL)","status":"COMPLETED","status_verified_date":"2014-04","start_date":"2009-01","start_date_type":null,"primary_completion_date":"2011-09","primary_completion_date_type":"ACTUAL","completion_date":"2013-05","completion_date_type":"ACTUAL","phases":["PHASE4"],"tickers":["GSK"]}